Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study.

doi:10.1016/j.ebiom.2019.10.024

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Interleukin-18 and outcome after allogeneic stem cell transplantation: A retrospective cohort study.

EBioMedicine - 1 Nov 2019

Radujkovic Aleksandar, Kordelas Lambros, Dai Hao, Schult David, Majer-Lauterbach Joshua, Beelen Dietrich, Müller-Tidow Carsten, Dreger Peter, Luft Thomas

Abstract excerpt

BACKGROUND: Interleukin-18 (IL-18) is involved in endothelial activation and dysfunction, and in the pathogenesis and severity of acute graft-versus-host disease (aGVHD). Its relevance for patient outcome after allogeneic stem cell transplantation (alloSCT) has not yet been comprehensively addressed. METHODS: Pre-transplant serum levels of free IL-18 were retrospectively assessed in a cohort of 589 patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cause of Death
Share to Graft vs Host Disease

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Hematopoietic Stem Cell Transplantation

Share to Incidence

Share to Interleukin-18

Share to Multivariate Analysis

Share to Neutrophils

Share to Transplantation, Homologous

Source

Open in PubMed Open full text

Identifiers

PMID: 31680001
DOI: 10.1016/j.ebiom.2019.10.024
PMCID: PMC6945194

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.